Key messages from IGCS 2010
Dr Richard Barakat - Memorial Sloan-Kettering Cancer Center, New York, USA
7 Dec 2010
GOG-218: Bevacizumab plus standard chemo for ovarian cancer
Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA
10 Nov 2010
Bevacizumab as part of standard first line treatment of ovarian cancer
Prof Jonathan Ledermann - University College London, UK
10 Nov 2010
The ICON7 trial
Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK
1 Nov 2010
ESTRO 2010 - Snapshots from the conference
European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-1...
25 Oct 2010
ESTRO 2010 Highlights
Professor Gordon McVie - European Institute of Oncology
6 Oct 2010
The role of ESTRO in the development of gynaecological cancer treatment
Prof Richard Pötter - Medical University of Vienna, Austria
6 Oct 2010
The rise in rates of endometrial cancer
Dr Paul Cornes, Bristol Oncology Centre, UK
3 Aug 2010
Optimising adjuvant therapy in the treatment of early stage endometrial cancer p...
Dr Carien Creutzberg - Leiden University Medical Center, Netherlands
2 Aug 2010
Key advances in ovarian cancer from ASCO 2010
Dr Prof Jonathan Ledermann - UCL Cancer Institute, UK
22 Jul 2010
Ovarian cancer research
Professor Stan Kaye - Institute of Cancer Research, London, UK
20 Jul 2010
NKTR-102: a new drug for treating platinum-resistant or refractory ovarian cance...
Professor Ignace Vergote - Catholic University of Leuven, Belgium
25 Jun 2010
